It can be challenging to find a brief, current review on cutting edge topics. Here we provide "white papers," which are brief overviews on current topics written by Society members who are experts in these areas. The topics of the white papers will vary over time depending upon what is new, evolving, or of current interest. All papers have undergone review by the SBI Scientific Advisory Committee and approved by the SBI Board of Directors. We hope that you will find these helpful.
Unless otherwise stated, the content of the white papers reflects the perspective of the authors and not necessarily the position of the Society of Breast Imaging.
Abbreviated Breast MR
Author: Janice S. Sung, MD, FSBI
Mammography is the primary imaging modality used for breast cancer screening, as it is cost effective, widely available, and the only imaging modality validated by multiple randomized controlled trials and meta-analyses to reduce breast cancer mortality. The mortality reduction achieved by mammographic screening averages 30% in randomized trials, and approaches and even exceeds 40% in observational and case control studies of women actually screened (1-5). Early detection through breast cancer screening also results...
September 25, 2018
Molecular Imaging Agents for Breast Cancer
Author: Amy M. Fowler, MD, PhD
Molecular imaging is a promising approach for achieving precision medicine. It can provide important functional information for improved diagnosis, treatment planning, prognostic and predictive information and evaluation of treatment response for cancer patients. The purpose of this article is to review the current status of molecular...
May 31, 2017
Current Status of Dedicated Nuclear Breast Imaging
Author: Wendie A. Berg, MD, PhD, FACR, FSBI
Interest in nuclear medicine-based breast imaging is increasing as advances in technology allow for lower dose of radiotracer and confirm high sensitivity for the detection of in-breast cancers. These tools may have roles as we develop tailored breast imaging in our efforts to provide personalized, value-based care for our...
May 2, 2017
Contrast Enhanced Digital Mammography
Authors: John Lewin, MD, FSBI & Maxine Jochelson, MD, FSBI
Screening mammography has been shown to reduce breast cancer mortality in randomized clinical trials. It has been an effective screening test for the past 4 decades due to its short exam time, patient convenience and low cost. The sensitivity of mammography for the detection of cancer in screening populations...
May 1, 2017
Breast Cancer Staging: Physiology Trumps Anatomy
Author: Maxine Jochelson, MD, FSBI
The purpose of this paper is to address the importance of physiologic imaging for the staging and follow up of patients with breast cancer according to the principles of precision medicine. Precision medicine is the “tailoring of medical treatment to the individual characteristics, needs and preferences of a patient during all...
May 1, 2017
Breast Density and Supplemental Screening
Authors: Wendie A. Berg, MD, PhD, FACR, FSBI & Jennifer A. Harvey, MD, FACR, FSBI
Dense breast tissue is common and normal. About 40% of women over the age of 40 years have dense breasts (1). Dense breasts are more common in younger women and the breasts tend to become more replaced by fat as the...
May 1, 2017
Digital Breast Tomosynthesis for Screening and Diagnostic Imaging
Authors: Emily F. Conant, MD, FSBI & Liane Philpotts, MD, FSBI
Digital breast tomosynthesis (DBT), which was FDA approved in 2011, is rapidly emerging as the new standard of care for x-ray imaging of the breast. Multiple studies have shown that when DBT is coupled with conventional 2D mammography,...
May 1, 2017